Does LERCANIDIPINE Cause Product administration error? 13 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Product administration error have been filed in association with LERCANIDIPINE. This represents 0.4% of all adverse event reports for LERCANIDIPINE.
13
Reports of Product administration error with LERCANIDIPINE
0.4%
of all LERCANIDIPINE reports
4
Deaths
10
Hospitalizations
How Dangerous Is Product administration error From LERCANIDIPINE?
Of the 13 reports, 4 (30.8%) resulted in death, 10 (76.9%) required hospitalization, and 4 (30.8%) were considered life-threatening.
Is Product administration error Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LERCANIDIPINE. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does LERCANIDIPINE Cause?
Acute kidney injury (424)
Hypotension (401)
Fall (323)
Hypertension (197)
Hyperkalaemia (176)
Drug ineffective (149)
Diarrhoea (122)
Hyponatraemia (122)
Renal impairment (120)
Oedema peripheral (114)
What Other Drugs Cause Product administration error?
HYDROXYPROGESTERONE CAPROATE (972)
ACETAMINOPHEN (666)
CENEGERMIN-BKBJ (613)
LEUPROLIDE (595)
EVOLOCUMAB (565)
ADALIMUMAB (543)
METHYLPHENIDATE (414)
OLMESARTAN MEDOXOMIL (314)
ASPIRIN (241)
SECUKINUMAB (225)
Which LERCANIDIPINE Alternatives Have Lower Product administration error Risk?
LERCANIDIPINE vs LETAIRIS
LERCANIDIPINE vs LETERMOVIR
LERCANIDIPINE vs LETROZOLE
LERCANIDIPINE vs LETROZOLE\RIBOCICLIB
LERCANIDIPINE vs LEUCOVORIN